[Lower respiratory tract infections related to Stenotrophomonas maltophilia and Acinetobacter baumannii].

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Revue de Pneumologie Clinique

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.pneumo.2013.02.005PMID 23583504
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen

  2012cited by this paper
• [Emerging Acinetobacter baumannii infections and factors favouring their occurrence].

  2012cited by this paper
• Stenotrophomonas maltophilia Infections in a General Hospital: Patient Characteristics, Antimicrobial Susceptibility, and Treatment Outcome

  2012cited by this paper
• Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.

  2012cited by this paper
• High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia.

  2011cited by this paper
• Efficacy of rifampin, in monotherapy and in combinations, in an experimental murine pneumonia model caused by panresistant Acinetobacter baumannii strains

  2011cited by this paper
• Bacteriological Differences Between COPD Exacerbation and Community-Acquired Pneumonia

  2011cited by this paper
• Prognosis of acute respiratory distress syndrome in neutropenic cancer patients

  2011cited by this paper
• Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease.

  2011cited by this paper
• Stenotrophomonas maltophilia in the respiratory tract of medical intensive care unit patients

  2011cited by this paper
• Ventilator-associated pneumonia: the clinical pulmonary infection score as a surrogate for diagnostics and outcome.

  2010cited by this paper
• Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.

  2010cited by this paper
• Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients.

  2010cited by this paper
• Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.

  2009cited by this paper
• Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units

  2009cited by this paper
• Stenotrophomonas maltophilia: an emerging opportunist human pathogen.

  2009cited by this paper
• Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia

  2008cited by this paper
• Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia

  2008cited by this paper
• A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.

  2008cited by this paper
• Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence.

  2008cited by this paper
• Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.

  2008cited by this paper
• Acinetobacter baumannii: Emergence of a Successful Pathogen

  2008cited by this paper
• High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii

  2007cited by this paper
• Community-acquired Acinetobacter infections

  2007cited by this paper
• Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer.

  2007cited by this paper
• Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii.

  2007cited by this paper
• An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii

  2007cited by this paper
• Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa

  2007cited by this paper
• Antimicrobial therapy for Stenotrophomonas maltophilia infections

  2007cited by this paper
• Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome

  2006cited by this paper
• Multiple-drug–resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome*

  2006cited by this paper
• Prospective evaluation of emerging bacteria in cystic fibrosis.

  2005cited by this paper
• Overview of nosocomial infections caused by gram-negative bacilli.

  2005cited by this paper
• Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings

  2005cited by this paper
• Use of colistin in the treatment of multiple-drug-resistant gram-negative infections.

  2005cited by this paper
• Antibiotic combinations significantly more active than monotherapy in an in vitro infection model of Stenotrophomonas maltophilia.

  2005cited by this paper
• Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome.

  2005cited by this paper
• Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.

  2005cited by this paper
• Clinical impact and pathogenicity of Acinetobacter.

  2005cited by this paper
• Class 1 Integrons Increase Trimethoprim-Sulfamethoxazole MICs against Epidemiologically Unrelated Stenotrophomonas maltophilia Isolates

  2004cited by this paper
• Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis

  2004cited by this paper
• Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.

  2004cited by this paper
• Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.

  2004cited by this paper
• Case-control study of Stenotrophomonas maltophilia acquisition in cystic fibrosis patients

  2004cited by this paper
• Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

  2003cited by this paper
• Risk Factors For Stenotrophomonas Maltophilia Bacteremia In Oncology Patients: A Case–Control Study

  2003cited by this paper
• Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients.

  2002cited by this paper
• Ventilator-associated pneumonia.

  2002cited by this paper
• Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia.

  2002cited by this paper
• The increasing role of Acinetobacter species as nosocomial pathogens

  2001cited by this paper
• Expression of Multidrug Efflux Pump SmeDEF by Clinical Isolates of Stenotrophomonas maltophilia

  2001cited by this paper
• Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999).

  2001cited by this paper
• Typing of 154 clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and determination of the in vitro susceptibilities of these strains to 28 antibiotics.

  2000cited by this paper
• Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis

  2000cited by this paper
• Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia.

  2000cited by this paper
• Outbreak of Stenotrophomonas maltophilia bacteremia in allogenic bone marrow transplant patients: role of severe neutropenia and mucositis.

  2000cited by this paper
• Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD.

  1999cited by this paper
• Susceptibility Surveillance among Gram-Negative Bacilli at a Cancer Center

  1999cited by this paper
• Survival of Acinetobacter baumannii on bed rails during an outbreak and during sporadic cases.

  1999cited by this paper
• Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease.

  1999cited by this paper
• Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia

  1998cited by this paper
• Exceptional desiccation tolerance of Acinetobacter radioresistens.

  1998cited by this paper
• Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods

  1997cited by this paper
• Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features

  1996cited by this paper
• Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods

  1996cited by this paper
• Stenotrophomonas maltophilia in cystic fibrosis patients

  1995cited by this paper
• A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy

  1994cited by this paper
• Nosocomial colonization and infection with multiresistant Acinetobacter baumannii: outbreak delineation using DNA macrorestriction analysis and PCR-fingerprinting.

  1993cited by this paper
• Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay.

  1993cited by this paper
• Hospital infection with Acinetobacter spp.: an increasing problem.

  1991cited by this paper
• Nosocomial respiratory tract infection and colonization with Acinetobacter calcoaceticus. Epidemiologic characteristics.

  1978cited by this paper
• [Studies on bacterial taxonomy. X. The revision of species under Acromobacter group].

  1954cited by this paper

• The clinical and epidemiological risk factors of infections due to multi-drug resistant bacteria in an adult intensive care unit of University Hospital Center in Marrakesh-Morocco.

  2020cites this paper
• Antibiotic Resistance Pattern of Acinetobacter baumannii Strains Isolated from Different Clinical Specimens and Their Sensibility Against Bioactive Molecules Produced by Actinobacteria

  2019cites this paper
• Granulometry, microbial composition and biological activity of dusts collected in French dairy farms

  2017cites this paper
• Acinetobacter baumannii bacteremia, a rare complication of endoscopic retrograde cholagiopancreatography!

  2014cites this paper
• Elucidating pathogenic determinants in stenotrophomonas maltophilia pathogenesis

  2014cites this paper